Explore All Access
Check if your research matches the topics covered in Drugs of the Future?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drugs of the Future : Impact Factor & More
eISSN: 2013-0368pISSN: 0377-8282
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Drugs of the Future Key Metrics
CiteScore 
0.2
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.06
Topics Covered on Drugs of the Future
Medical genetics
Receptor antagonist
Molecular targets
Monoclonal antibody
Topoisomerase
Cancer immunotherapy
DNA Gyrase Inhibitors
Calcitonin gene-related peptide
RNA polymerase
Anaphylatoxin C5a
Resistant hypertension
Margetuximab
Autism spectrum disorder
Cancer research
Cytochrome b
Calcitonin gene-related peptide receptor antagonist
Drug discovery
Cancer therapy
Antibody-drug conjugate
Dipeptidyl peptidase
Drugs of the Future Journal Specifications
| Overview | |
| Publisher | PROUS SCIENCE, SAU-THOMSON REUTERS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Drugs of the Future ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs of the Future
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
- 1 Jan 2023
- Drugs of the Future
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
- 1 Jan 2023
- Drugs of the Future
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
- 1 Jan 2023
- Drugs of the Future
Sabatolimab. TIM-3-targeting monoclonal antibody, Treatment of myelodysplastic syndrome, Treatment of acute myeloid leukemia
- 1 Jan 2022
- Drugs of the Future
American Society of Clinical Oncology (ASCO) - 58th Annual Meeting. Chicago/Virtual - June 3-7, 2022
- 1 Jan 2022
- Drugs of the Future
Experimental and in silico approaches to target selection and tractability for drug discovery. Highlights from the Society for Medicines Research Conference. London - March 21, 2022
- 1 Jan 2022
- Drugs of the Future
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
- 1 Jan 2023
- Drugs of the Future
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
- 1 Jan 2023
- Drugs of the Future
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
- 1 Jan 2023
- Drugs of the Future
Sabatolimab. TIM-3-targeting monoclonal antibody, Treatment of myelodysplastic syndrome, Treatment of acute myeloid leukemia
- 1 Jan 2022
- Drugs of the Future
American Society of Clinical Oncology (ASCO) - 58th Annual Meeting. Chicago/Virtual - June 3-7, 2022
- 1 Jan 2022
- Drugs of the Future
Experimental and in silico approaches to target selection and tractability for drug discovery. Highlights from the Society for Medicines Research Conference. London - March 21, 2022
- 1 Jan 2022
- Drugs of the Future
Compare Similar Journals with Drugs of the Future
Select Journals to Compare with Drugs of the Future
Total journals - 5
You can select up to 3 Journals at a time
Japanese Journal of Health Physics
Publisher: Japan Health Physics Society
Fisheries
Publisher: WILEY
TRANSACTIONS OF THE KANSAS ACADEMY OF SCIENCE
Publisher: KANSAS ACAD SCIENCE-KAS
Bone Marrow Transplantation
Publisher: SPRINGERNATURE
Journal of Thoracic and Cardiovascular Surgery
Publisher: MOSBY-ELSEVIER
0 Journals Selected to compare with
Drugs of the Future
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drugs of the Future
How long has Drugs of the Future been actively publishing? 
Drugs of the Future has been in operation since 1976 till date.
What is the publishing frequency of Drugs of the Future?
Drugs of the Future published with a Monthly frequency.
How many articles did Drugs of the Future publish last year?
In 2023, Drugs of the Future publsihed 3 articles.
What is the eISSN & pISSN for Drugs of the Future?
For Drugs of the Future, eISSN is 2013-0368 and pISSN is 0377-8282.
What is Citescore for Drugs of the Future?
Citescore for Drugs of the Future is 0.2.
What is SNIP score for Drugs of the Future?
SNIP score for Drugs of the Future is 0.06.
What is the SJR for Drugs of the Future?
SJR for Drugs of the Future is Q4.
Who is the publisher of Drugs of the Future?
PROUS SCIENCE, SAU-THOMSON REUTERS is the publisher of Drugs of the Future.
